Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharma... (ctors say their organization will mandat...)

Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit

Date:7/15/2009

ctors say their organization will mandate IV biologics be purchased from an authorized vendor (e.g., specialty pharmacy)."

About Formulary Advantages in Immune Biologics: Tightening Payer Control Offers Opportunities for Differentiation

The new Formulary Forum report is based on a survey of 50 pharmacy directors who control national, regional and state-level managed care organizations, as well as historical formulary data from Fingertip Formulary.

About Fingertip Formulary

Fingertip Formulary (www.FingertipFormulary.com), the leading provider of access to and insight into formulary data in the United States, offers comprehensive formulary data covering commercial, Medicaid, Medicare and PBM plans, among others. The company offers a variety of unique data and marketing solutions for the pharmaceutical industry, consultants and healthcare providers that provide access to and insight into formulary data. Fingertip Formulary is a Decision Resources, Inc. company.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Both HealthLeaders-InterStudy and Fingertip Formulary are Decision Resources, Inc. companies. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trad
'/>"/>

SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
2. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
3. Most Important Factors Driving Usage of Antibiotics in the ICU Setting are Availability in Intravenous Formulation, Activity Against Key Gram Negative Pathogens, Drug Interactions and Bactericidal Activity
4. New form of intravenous iron treats anemia in chronic kidney disease patients on dialysis
5. Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
6. New Bill Offers Medicare Reimbursement Fix for Intravenous Immune Globulin
7. Availability in Both Intravenous and Oral Formulation is a Leading Drug Attribute Surveyed Physicians Prefer for the Treatment of Urinary Tract Infections in the Hospital Setting
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. Immune deficiency linked to a type of eye cancer
10. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
11. Melanoma drug revs immune cells but cancer cells ignore it

Post Your Comments:

(Date:12/17/2009)... Physicians Healthcare Management Group, Inc. (Phyhealth) ... it has issued its financial statements for the ... are being posted today on the Pink Sheets ... Management Group, Inc. ,, Physicians Healthcare ... community-based health maintenance organizations (HMOs) that are owned ...

(Date:12/17/2009)... characteristics involved in the exposure of pregnant women to ... standing up or have to lift heavy objects, 63% ... are frequently exposed to some physical risk in their ... especially sensitive to exposure to workplace hazards", M Carmen ... at the Higher Centre for Public Health Research in ...

(Date:12/17/2009)... Stem cells that could one day provide therapeutic ... harvested from the tissue of the umbilical cord, just ... cells to treat some blood disorders, said University of ... version of the Journal of Biomedicine and ... be expanded to greater number, are remarkably stable and ...

(Date:12/17/2009)... Science in Human Resource Development Degree Online , ... ... Open enrollment has begun for Villanova’s newly online HR ... whose busy schedules can’t accommodate a campus-based program. With the ... in March 2010, location is no longer a barrier to ...

(Date:12/17/2009)... -- CareFusion Corporation (NYSE: CFN ) announced ... mini-tender offer by TRC Capital Corporation (TRC) to purchase ... representing approximately 1.8 percent of the shares of common ... is 4.62 percent below the share closing price of ... full trading day prior to the offer. CareFusion also ...

Breaking Medicine News(10 mins):Health News:Phyhealth Issues September 30, 2009 Financial Statements 2 Health News:Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work 2 Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3 Health News:CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital 2

[0] Phyhealth Issues September 30, 2009 Financial Statements [0] Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work [0] Umbilical cord could be new source of plentiful stem cells, say Pitt researchers [0] A World-Class HR Master's Degree Is Now Within Reach – 100% Online [0] CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital

... track record in supporting clinical trials, most notably in ... Phase I/II clinical testing center at the Walter Reed ... CRM is the premier clinical research organization supporting this ... capabilities, it looked to the National Institute of Allergy ...

... skyrocket over the next five ... according to Millennium Research Group, WALTHAM, Mass., Aug. ... for Women,s Health Imaging Systems 2008 report,the market for ... (MRI) coils, dedicated breast MRI systems, and,breast-specific gamma imaging ...

... Toledo Children,s Hospital and Good Samaritan Hospital, ... NORTH HOLLYWOOD, Calif., Aug. 7 IPC The,Hospitalist ... national hospitalist,physician group practice company, announced today that ... Hospital in Toledo,Ohio and Good Samaritan Hospital in ...

... reported financial results for the three and six months ended June ... ... EON) August 7, 2008 -- Total revenue for the three ... million, respectively, as compared to $496,000 and $999,000, respectively, for the ...

... Aug. 7 Micromet, Inc. (Nasdaq:,MITI), a biopharmaceutical ... for the treatment of cancer, inflammation and,autoimmune diseases, ... and six months ended June 30, 2008., ... and MedImmune presented a clinical update for the,BiTE(R) ...

... to $9.6 million from $4.9 million -, LISLE, ... or the "Company") (NASDAQ: SXCI , TSX: SXC), ... ended June 30, 2008. Financial,references are in U.S. dollars ... National Medical Health Card Systems,Inc. ("NMHC") on April 30, ...

Clinical Research Management gets contract for trials of therapeutics against infectious diseases Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 IPC The Hospitalist Company Enters Ohio and Pennsylvania Markets Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results Micromet, Inc. Reports Second Quarter 2008 Financial Results SXC Health Solutions announces second quarter financial results

(Date:12/17/2009)... ,Agendia, a world leader in molecular cancer ... Administration (FDA) cleared its MammaPrint breast,cancer recurrence test ... cancer recurrence test available to patients and physicians. ... four clearances for MammaPrint, covering,all aspects of this ... FDA clearance, along with our recently obtained CMS ...

(Date:12/17/2009)... (OTC Bulletin Board: SCIE) disclosed today that its Chairman ... to shareholders: ,, As the end of the year ... recent closing of a $4.3 million round of equity ... our business performance as we head into 2010. We ... We are increasing our sales and marketing activities and ...

(Date:12/17/2009)... Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX ) today ... President, Sales and Commercial Affairs. In this ... be responsible for all commercial activities, including pre-launch ... with the collaboration agreement between the Company and ... that emerge from the Company,s pipeline. Ms. ...

Breaking Medicine Technology:FDA Broadens Clearance for Agendia's MammaPrint(R) 2 SpectraScience Releases Shareholder Newsletter 2 SpectraScience Releases Shareholder Newsletter 3 SpectraScience Releases Shareholder Newsletter 4 SpectraScience Releases Shareholder Newsletter 5 Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2 Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3 Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4 Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 1 Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 2 OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 1 OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 2 OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 3 Common plants can eliminate indoor air pollutants 60694 1 Common plants can eliminate indoor air pollutants 60694 2

[0] FDA Broadens Clearance for Agendia's MammaPrint(R)[0] SpectraScience Releases Shareholder Newsletter [0] Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs

... April 27 The Villa Group is closely monitoring the ... appropriate steps to ensure the safety and health of all ... properties (located in Cabo San Lucas, Puerto Vallarta, and Nuevo ... the outbreaks have occurred. No cases have been reported in ...

... Men taking generic drugs may be more likely ... than if they were using branded medications, according to ... a study at the 104th Annual Scientific Meeting of ... for alpha blockers and 5-alpha reductase inhibitors (5-ARIs), two ...

Other Medicine Technology:The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak 2 Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms 2

The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms

... to remove bone cement speedily and efficiently. , ... cement at the point of contact, allowing it ... feature of the apparatus is its ability to ... to the operator instantly. Probe position can thus ...

... DEFIANT 95% media meets today's ... and contaminant reduction. The unique, ... manufacture DEFIANT filters creates a ... with respect to initial efficiency, ...

The kneeGRIP™ is designed to secure the position of the lower extremity with the knee flexed....

The De mayo Hip Positioner is simple, adjustable, has lateral decubitus positioning, and can be set up with six simple steps....

Medicine Products:

OSCAR Ultrasonic Bone Cement Remover Defiant 95% Bag Filter KneeGrip™De Mayo Hip Positioner

Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharma...(ctors say their organization will mandat...),Health